H.C. Wainwright analyst Ram Selvaraju has reiterated their bullish stance on PYPD stock, giving a Buy rating yesterday. Ram Selvaraju has ...

In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Plus Therapeutics (PSTV – Research Report), with a ...

Viking Holdings has significant fleet expansion. Read why I see this small period of consolidation as a good opportunity to ...

DRChoksey FinServ has recommended six stocks to buy this month which it projects to have the upside potential of up to 28%.

Read here for an update on Tesla's upcoming catalysts in Oct., including the robotaxi event and Q3 release, and TSLA's ...

ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Shares of several companies including Godrej Properties, Dabur, Marico, JSW Steel, and Titan, among others, will be in the ...

Looking to buy ASX shares with strong growth potential? Here are three Aussie stocks brokers just upgraded to buys and one to ...

Toll Brothers (TOL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...

Tesla is expected to unveil its autonomous "robotaxi" on Oct. 10, with analysts expecting details about the new vehicle and other potential announcements like a lower-cost model or updates to its ...

On Tuesday, Denali Therapeutics Inc (DNLI) stock saw a decline, ending the day at $28.67 which represents a decrease of $-0.46 or -1.58% from the prior close of $29.13. The stock opened at $29.18 and ...

On Tuesday, Kilroy Realty Corp (KRC) stock saw a decline, ending the day at $38.27 which represents a decrease of $-0.43 or -1.11% from the prior close of $38.7. The stock opened at $38.58 and touched ...